Notably, an higher CD4+/CD8+ ratio at the of leukapheresis, as well as higher frequency of CD8+CD45RO-CD27+ T cells (i.e., early lineage CD8+ T cells) were the only factors associated with clinical response in these multiple myeloma patients. The gene discussed is CD27; the disease is AL amyloidosis.